Leaflet TEICOPLANINA MYLAN 400mg powder for solution for injection / infusion or oral solution
Indicated for: bacterial infections
Route of administration: injectable / infusion / oral
Substance: teicoplanin (glycopeptide antibiotic)
ATC: J01XA02 (Antiinfectives for systemic use | Other antibacterials | Glycopeptide antibacterials)
Dose adjustment may be needed in kidney disease.
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Seek medical advice if severe or persistent diarrhea occurs.
Teicoplanin is a glycopeptide antibiotic used for the treatment of severe bacterial infections caused by Gram-positive bacteria, including skin, bone, and joint infections, as well as endocarditis. It works by inhibiting bacterial cell wall synthesis, thereby destroying the bacteria.
The medication is administered via intravenous or intramuscular injection, as directed by a doctor. The dosage and duration of treatment are adjusted based on the severity of the infection and the patient's response.
Patients should be monitored for potential side effects, such as injection site reactions, skin rashes, or changes in kidney function. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, skin rashes, and nausea. In rare cases, severe reactions such as kidney failure or serious allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about TEICOPLANINA MYLAN 400mg
- Substance: teicoplanin
- Date of latest medicines list: 01-04-2022
- Product code: W68625001
- Concentration: 400mg
- Pharmaceutical form: powder for solution for injection / infusion or oral solution
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for teicoplanin
- 100mg
- 200mg
- 400mg